Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU-Reference-Cited by-同舟云学术

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU

Published:2024 Issue: Volume: Page:
ISSN:1130-0108
Container-title:Revista Española de Enfermedades Digestivas
language:
Short-container-title:Rev Esp Enferm Dig

Author:

Riveiro-Barciela Mar,carballal Sabela,Díaz-González Álvaro,Mañosa Miriam,Gallgo-Plazas Javier,Cubiella Joaquín,Jiménez-Fonseca Paula,Varela María,Menchén Luis,Sangro Bruno,Fernández-Montes Ana,Mesonero Francisco,Rodríguez-Gandía Miguel Ángel,Rivera Fernando,Londoño María-Carlota

Publisher

Sociedad Espanola de Patologia Digestiva (SEPD)

Reference320 articles.

1. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

2. Sistema GRADE: clasificación de la calidad de la evidencia y graduación de la fuerza de la recomendación

3. Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors

4. Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial

5. AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposal;Lung Cancer;2024-05

2. Extensive Colitis Associated with Ixekizumab;Revista Española de Enfermedades Digestivas;2024